- CADFEM: Dr. B. Bennett, Dr. Hays, Dr. G. Bennett
- Biofourmis- AIM POWER: Dr. B. Bennett (heart failure)
- Ancora- Corcinch: Dr. Crowder, Dr. G. Bennett (heart failure)
- Abbott- Catalyst: Dr. Crowder (atrial fibrillation)
- Novartis- Inclisiran: Dr. Hays (ACS lipid trial)
- Novartis- Victorian 2 Prevent; Dr. Hays (lipid trial)
- Medtronic- Define Afib: Dr. McCearley (atrial fibrillation/LinQ)
- Bayer-Oceanic AFib: Dr. Stone (medication for atrial fibrillation)
- ACC-Transform 3: Dr. Stokes (optimize medical therapy in cardiovascular disease)
- Encore Medical- PerForm: Dr. Crowder (Patent Foramen Ovale device)
- Amgen-Evolve: Dr. B.Bennett (lipid management after heart attack)
All of our currently enrolling studies can be looked up at https://clinicaltrials.gov/.